Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth

NCT06648850 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

1120

Enrollment

INDUSTRY

Sponsor class

Conditions

Telogen Effluvium
Female Pattern Hair Loss
Female Pattern Hair Loss, Androgenic Alopecia
Male Pattern Baldness
Androgenetic Alopecia
Androgenetic Alopecia (AGA)

Interventions

DRUG: DA-001
OTHER: Placebo
DRUG: Phenylephrine
OTHER: DA-001 Topical + DA-005 Oral (HIF-1α supplement)
OTHER: DA-010 - Oral Phenylephrine 20 mg + DA-005 Oral (HIF-1α supplement)
DRUG: Phenylephrine Topical 0.25% + Intact Pro Topical
OTHER: Phenylephrine + Intact Pro + DA-005 Oral (HIF-1α supplement)

Sponsor

Applied Biology, Inc.

Collaborators

[object Object]
[object Object]